By Jeff Montgomery (August 26, 2024, 7:06 PM EDT) — A private equity investor in biotech Vividion Therapeutics Inc., recently acquired by Bayer Corp. for up to $2 billion, sued the company’s co-founder and others in Delaware’s Court of Chancery on Monday, accusing them of secretly diverting to another company intellectual property worth “hundreds of millions, if not billions.”…
Law360 is on it, so you are, too.
A Law360 subscription puts you at…
Read More…
Source: https://www.law360.com/articles/1873605/biotech-investor-sues-in-chancery-over-alleged-ip-diversions